Show simple item record

dc.contributor.authorMäki-Heikkilä, Rikhard
dc.contributor.authorKarjalainen, Jussi
dc.contributor.authorParkkari, Jari
dc.contributor.authorHuhtala, Heini
dc.contributor.authorValtonen, Maarit
dc.contributor.authorLehtimäki, Lauri
dc.date.accessioned2022-06-30T06:12:57Z
dc.date.available2022-06-30T06:12:57Z
dc.date.issued2022
dc.identifier.citationMäki-Heikkilä, R., Karjalainen, J., Parkkari, J., Huhtala, H., Valtonen, M., & Lehtimäki, L. (2022). High training volume is associated with increased prevalence of non-allergic asthma in competitive cross-country skiers. <i>BMJ Open Sport & Exercise Medicine</i>, <i>8</i>(2), Article e001315. <a href="https://doi.org/10.1136/bmjsem-2022-001315" target="_blank">https://doi.org/10.1136/bmjsem-2022-001315</a>
dc.identifier.otherCONVID_147121747
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/82120
dc.description.abstractBackground Cross-country skiers have a high prevalence of asthma, but its phenotypes and association with success in competitions are not known. Objective To investigate, by means of a postal survey, the relative proportions of allergic and non-allergic asthma in competitive cross-country skiers compared with the general population, to study how performance level and training volume are related to asthma and its type and to assess the possible risk factors for allergic and non-allergic asthma in competitive skiers. Methods All Finnish cross-country skiers enrolled in the largest national competitions in winter 2019 (n=1282), and a random sample (n=1754) of the general population of the same age were sent a postal questionnaire. The response rate was 27.4% (n=351) for skiers and 19.5% (n=338) for the controls. International Ski Federation (FIS) ranking points measured the level of success in skiers. Asthma was defined as self-reported, physician-diagnosed asthma. Asthma was considered allergic if associated with doctor-diagnosed allergy, and exposure to allergens provoked asthma symptoms. Results The prevalence of asthma was higher in skiers than in the controls (25.9% vs 9.2%, p<0.001), and it was the highest (56.1%) in the most successful quartile of skiers. Asthma was more often non-allergic in skiers than in the controls (60.1% vs 38.7%, p=0.036). Being a skier came with a higher risk for non-allergic (OR 5.05, 95% CI 2.65 to 9.61) than allergic asthma (OR 1.92, 1.08–3.42). Using multivariable regression analysis, training volume was associated with non-allergic asthma, while age, family history of asthma and allergic rhinitis were associated with allergic asthma. Conclusion The prevalence of asthma is the highest in the most successful cross-country skiers. The asthma in skiers is mostly non-allergic compared with the general population of the same age. The most important risk factor for non-allergic asthma in skiers is high training volume.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesBMJ Open Sport & Exercise Medicine
dc.rightsCC BY-NC 4.0
dc.subject.otherhigh training volume
dc.subject.otherprevalence
dc.subject.othernon-allergic asthma
dc.subject.othercross-country skiers
dc.titleHigh training volume is associated with increased prevalence of non-allergic asthma in competitive cross-country skiers
dc.typeresearch article
dc.identifier.urnURN:NBN:fi:jyu-202206303720
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn2055-7647
dc.relation.numberinseries2
dc.relation.volume8
dc.type.versionpublishedVersion
dc.rights.copyright© Author(s) (or their employer(s)) 2022.
dc.rights.accesslevelopenAccessfi
dc.type.publicationarticle
dc.subject.ysosairastavuus
dc.subject.ysoastma
dc.subject.ysohuippu-urheilijat
dc.subject.ysohiihtäjät
dc.subject.ysoharjoittelu
dc.subject.ysohengityselinten taudit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p3556
jyx.subject.urihttp://www.yso.fi/onto/yso/p19468
jyx.subject.urihttp://www.yso.fi/onto/yso/p25224
jyx.subject.urihttp://www.yso.fi/onto/yso/p15138
jyx.subject.urihttp://www.yso.fi/onto/yso/p26412
jyx.subject.urihttp://www.yso.fi/onto/yso/p2304
dc.rights.urlhttps://creativecommons.org/licenses/by-nc/4.0/
dc.relation.doi10.1136/bmjsem-2022-001315
jyx.fundinginformationThis study was financially supported by Tampere Tuberculosis foundation and Foundation of the Finnish Anti-Tuberculosis Association, Väinö and Laina Kivi Foundation, Ida Montin Foundation, Urheiluopistosäätiö, Allergy Research Foundation and The Research Foundation of the Pulmonary Diseases.
dc.type.okmA1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY-NC 4.0
Except where otherwise noted, this item's license is described as CC BY-NC 4.0